Revisions SAB Biotherapeutics, Inc.

Equities

SABS

US78397T2024

Delayed Nasdaq 04:30:00 2024-05-08 pm EDT 5-day change 1st Jan Change
4.1 USD +0.24% Intraday chart for SAB Biotherapeutics, Inc. 0.00% -40.36%

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

  1. Stock Market
  2. Equities
  3. SABS Stock
  4. Revisions SAB Biotherapeutics, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW